Compare MXL & ATEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MXL | ATEC |
|---|---|---|
| Founded | 2003 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 1.6B |
| IPO Year | 2009 | 2006 |
| Metric | MXL | ATEC |
|---|---|---|
| Price | $68.51 | $9.29 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 11 |
| Target Price | ★ $31.67 | $22.00 |
| AVG Volume (30 Days) | ★ 4.1M | 2.3M |
| Earning Date | 04-23-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 46.08 | 15.04 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $478,596,000.00 | $101,739,000.00 |
| Revenue This Year | $22.10 | $18.97 |
| Revenue Next Year | $10.70 | $16.70 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.07 | $9.15 |
| 52 Week High | $63.52 | $23.29 |
| Indicator | MXL | ATEC |
|---|---|---|
| Relative Strength Index (RSI) | 84.04 | 33.81 |
| Support Level | $15.30 | N/A |
| Resistance Level | N/A | $16.22 |
| Average True Range (ATR) | 4.98 | 0.64 |
| MACD | 4.15 | -0.10 |
| Stochastic Oscillator | 94.59 | 5.31 |
MaxLinear Inc is a provider of radio frequency and mixed-signal integrated circuits for cable and satellite broadband communications, the connected home, and for data center, metro, and long-haul fiber networks. The company's radio frequency receiver products capture and process digital and analog broadband signals to be decoded for various applications. Its product options include both radio frequency receivers and radio frequency receiver systems-on-chips. The company's products enable the distribution and display of broadband video and data content in a wide range of electronic devices.
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.